Make life easier with Clinical One Data Collection

Transformative digital strategies are needed for faster study start-up, to harmonize data from any source, and to streamline workflow. All to give today’s world what it wants—quicker results, with treatments reaching patients faster.

Left Hand Right Hand
Num 1

Siloed Systems v. Unified Platform

Siloed systems are unsustainable and risky, a unified platform is inevitable and necessary.

Num 2

Data Influx

Increasing complexity and volume of clinical data is introducing compliance and quality risks. There is a solution.

Num 3

Change Management

People, process and technology must adapt.

Clinical Leader Live: EDC Transformation to Meet Clinical Trial Demands

The beginning

A look back at clinical research and how the need to manage its data compels the industry to change.

How did we get there?

Listen to eClinical veteran Steve Rosenberg share his perspective on the past 30 years, and where data collection is going in the future.

The Time Is Now for Transformation In Clinical Trial Data Collection

The swift transition to virtual clinical trials during the COVID-19 pandemic demonstrated that eClinical solutions for collecting data and conducting visits are not only possible but can bring real benefits to clinical research studies, and ultimately patients.

Read the white paper

Clinical One Data Collection

Oracle Health Sciences Clinical One Data Collection goes beyond EDC, allowing you to collect data sets from any source and harmonize them in a single, unified place to draw valuable, beneficial clinical insight.

New research: Top concerns regarding remote data collection

The onset of the COVID-19 pandemic made it quickly apparent that new strategies would be necessary to operationalize the decentralization of data collection to meet patient needs while also ensuring quality, compliance, and regulatory-ready data. A recent survey shows the top concerns life science organizations have around the decentralized approach to data collection.

Read the article

Four Ways the Pandemic is Impacting the Clinical Data Landscape

Covid-19 has accelerated an already-existing shift towards decentralized clinical trials, bringing new challenges and reshaping methods for patient engagement and data collection. A recent survey of leading biopharmaceutical companies, medical device companies, and contract research organizations (CROs), revealed that 76% of individuals involved in clinical trials said that the COVID-19 pandemic has accelerated their adoption of decentralized clinical trial methods.

View the infographic